Menu
Back to Journals » Biologics: Targets and Therapy » Volume 1 » Issue 3
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (502)
- Volume 18, 2024 (6)
- Volume 17, 2023 (17)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 1, 2007
Gefitinib and high-dose fractionated radiotherapy for carcinomatous encephalitis from non-small cell lung carcinoma
Eric T Wong, Julian K Wu, Anand Mahadevan
Biologics: Targets and Therapy 2007, 1:321-324
Published Date: 15 January 2008
Ultrasound assessment of salivary glands in patients with primary Sjögren's syndrome treated with rituximab: Quantitative and Doppler waveform analysis
Sandrine Jousse-Joulin, Valérie Devauchelle-Pensec, Johanne Morvan, Bruno Guias, Yvon Pennec, et al
Biologics: Targets and Therapy 2007, 1:311-319
Published Date: 15 January 2008
Efalizumab in the treatment of psoriasis
Wolf-Henning Boehncke
Biologics: Targets and Therapy 2007, 1:301-309
Published Date: 15 January 2008
Agalsidase alfa (Replagal™) in the treatment of Anderson-Fabry disease
Gregory M Pastores
Biologics: Targets and Therapy 2007, 1:291-300
Published Date: 15 January 2008
The management of patients with congenital von Willebrand disease during surgery or other invasive procedures: focus on antihemophilic factor/von Willebrand factor complex
Massimo Franchini, Giuseppe Lippi
Biologics: Targets and Therapy 2007, 1:285-289
Published Date: 15 January 2008
A review of antisense therapeutic interventions for molecular biological targets in asthma
Florin-Dan Popescu, Florica Popescu
Biologics: Targets and Therapy 2007, 1:271-283
Published Date: 15 January 2008
Nonsurgical treatment of male infertility: specific and empiric therapy
Marcello Cocuzza, Ashok Agarwal
Biologics: Targets and Therapy 2007, 1:259-269
Published Date: 15 January 2008
The molecular genetics of breast cancer and targeted therapy
Rachel Suter, James A Marcum
Biologics: Targets and Therapy 2007, 1:241-258
Published Date: 15 January 2008
Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancer
Elizabeth S Henson, James B Johnston, Marek Los, Spencer B Gibson
Biologics: Targets and Therapy 2007, 1:229-239
Published Date: 15 January 2008
90Yttrium ibritumomab tiuxetan in the treatment of non-Hodgkin's lymphoma: current status and future prospects
Samuel A Jacobs
Biologics: Targets and Therapy 2007, 1:215-227
Published Date: 15 January 2008
The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept
Renaud Snanoudj, Carlos Frangié, Benjamin Deroure, Hélène François, Caroline Créput, et al
Biologics: Targets and Therapy 2007, 1:203-213
Published Date: 15 January 2008
A review of treatment of Pompe disease in infants
Yin-Hsiu Chien, Wuh-Liang Hwu
Biologics: Targets and Therapy 2007, 1:195-201
Published Date: 15 January 2008
Targeted therapy of advanced non-small cell lung cancer: the role of bevacizumab
Thomas E Stinchcombe
Biologics: Targets and Therapy 2007, 1:185-194
Published Date: 15 January 2008
Editorial: On the diversity of biological therapeutics ||Free Paper||
Sanjay Awasthi
Biologics: Targets and Therapy 2007, 1:183-184
Published Date: 15 January 2008